Measurement of the activated partial thromboplastin time from a capillary (fingerstick) sample of whole blood. A new method for monitoring heparin therapy.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  American Journal of Clinical Pathology

• Publication date

  1991-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/AJCP/95.2.222PMID 1992612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study.

  1989cited by this paper
• Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times.

  1989cited by this paper
• Cost effectiveness of monitoring warfarin therapy using standard versus capillary prothrombin times.

  1989cited by this paper
• A novel whole blood capillary technic for measuring the prothrombin time.

  1987cited by this paper
• Mechanism of Action and Monitoring of Anticoagulants

  1986cited by this paper
• The Effects of Inaccurate Blood Sample Volume on Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT)

  1982cited by this paper
• Studies of Phospholipid Reagents Used in Coagulation II: Factors Influencing Their Sensitivity to Heparin

  1981cited by this paper
• Laboratory monitoring of heparin. Effect of reagents and instruments on the activated partial thromboplastin time.

  1981cited by this paper
• Unsuitability of evacuated tubes for monitoring heparin therapy by activated partial thromboplastin time.

  1981cited by this paper
• Laboratory monitoring of heparin therapy--the effect of different salts of heparin on the activated partial thromboplastin time.

  1980cited by this paper
• Heparin and the activated partial thromboplastin time--a difference between the in-vitro and in-vivo effects and implications for the therapeutic range.

  1980cited by this paper
• Incorrect least-squares regression coefficients in method-comparison analysis.

  1979cited by this paper
• Erroneous activated partial thromboplastin time.

  1978cited by this paper
• Variation among commercial activated partial thromboplastin time reagents in response to heparin.

  1977cited by this paper
• Control of Heparin Therapy With Activated Partial Thromboplastin Times

  1967cited by this paper
• The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

  1961cited by this paper
• Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

  1953cited by this paper

• EKITE phase 2: A valuable readily available resource for patient education on thrombosis and warfarin anticoagulation therapy.

  2025cites this paper
• Point‐of‐care PT and aPTT in patients with suspected deficiencies of coagulation factors

  2016cites this paper
• Intensive Care Point of care and central laboratory determina-tions of the aPTT are not interchangeable in surgical intensive care patients

  2008cites this paper
• Anticoagulation Monitoring Part 1: Warfarin and Parenteral Direct Thrombin Inhibitors

  2005cites this paper
• Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin

  2005cites this paper
• Comparing a piezoelectric quartz crystal with an optical coagulometer in monitoring high-dose heparin therapy by determining whole blood activated partial thromboplastin time and activated clotting time

  2005cites this paper
• Editorial : Thrombolysis in Acute Myocardial Infarction : Treatment of the Underlying Coronary Artery Disease

  2005cites this paper
• Bedside Anticoagulant Testing

  2004cites this paper
• Key References: Anticoagulation Monitoring

  2004cites this paper
• [Point of care (POC) monitoring in anesthesia and intensive care--an overview of available POC systems].

  2003cites this paper
• Near-patient testing for coagulopathy after cardiac surgery.

  2003cites this paper
• Near‐patient testing of haemostasis in the operating theatre: an approach to appropriate use of blood in surgery

  2003cites this paper
• Point-Of-Care (POC) Monitoring in Anästhesie und Intensivmedizin - eine Übersicht über die zur Verfügung stehenden Möglichkeiten

  2003cites this paper
• Point-of-care testing for prothrombin time, but not activated partial thromboplastin time, correlates with laboratory methods in patients receiving aprotinin or epsilon-aminocaproic acid while undergoing cardiac surgery.

  2002cites this paper
• Kapilläre Thromboplastinzeit : Untersuchung zur Validität des INR-Wertes aus Kapillarblut bei Kindern mit und ohne Marcumartherapie mit Hilfe des CoaguChek-Systems

  2001influential citation
• New heparin dosing recommendations for patients with acute coronary syndromes.

  2001cites this paper
• Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients

  2001cites this paper
• The Role of Point-of-Care Anticoagulation Monitoring in Arterial and Venous Thromboembolic Disorders

  2000cites this paper
• Point-Of-Care (POC) Monitoring of Coagulation in the Critically Ill

  1999cites this paper
• A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators.

  1999cites this paper
• Bedside activated partial thromboplastin time monitoring: just a matter of time?

  1999cites this paper
• Heparin and Other Indirect Antithrombin Agents

  1999cites this paper
• Optimal management of bleeding and transfusion in patients undergoing cardiac surgery.

  1999cites this paper
• The diagnostic accuracy of bedside and laboratory coagulation: procedures used to monitor the anticoagulation status of patients treated with heparin.

  1998cites this paper
• [Prothrombin time and thromboplastin time. On-site measurement of the prothrombin time and activated partial thromboplastin time of surgical patients with laser photometry].

  1998cites this paper
• College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.

  1998cites this paper
• Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

  1998cites this paper
• New bedside test for monitoring anticoagulation during hemodialysis.

  1998cites this paper
• Prothrombinzeit und Thromboplastinzeit On-site Messung der Prothrombinzeit und der Aktivierten Partiellen Thromboplastinzeit bei operativen Eingriffen mittels Laserphotometrie

  1998cites this paper
• Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings.

  1997cites this paper
• Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes.

  1997cites this paper
• Monitoring hemostasis.

  1996cites this paper
• The current and future status of critical care testing and patient monitoring.

  1995cites this paper
• Designing a point-of-care program for coagulation testing.

  1995cites this paper
• Predictors of the effect of heparin during cardiac catheterization.

  1995cites this paper
• Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.

  1995cites this paper
• Aprotinin Prolongs Whole Blood Activated Partial Thromboplastin Time but Not Whole Blood Prothrombin Time in Patients Undergoing Cardiac Surgery

  1995cites this paper
• Guidelines for point-of-care testing. Improving patient outcomes.

  1995cites this paper
• Exploring the medical need for alternate site testing. A clinician's perspective.

  1995cites this paper
• Monitoring Anticoagulant Therapy by Activated Partial Thromboplastin Time: Hirudin Assessment

  1994cites this paper
• Effect of analytic uncertainty of conventional and point-of-care assays of activated partial thromboplastin time on clinical decisions in heparin therapy.

  1994cites this paper
• Monitoring anticoagulation following intracoronary procedures: which method?

  1994cites this paper
• The TAMI Trials

  1994cites this paper
• On‐site Prothrombin Time, Activated Partial Thromboplastin Time, and Platelet Count A Comparison between Whole Blood and Laboratory Assays with Coagulation Factor Analysis in Patients Presenting for Cardiac Surgery

  1994cites this paper
• Intraoperative measurement of activated partial thromboplastin time and prothrombin time with a new compact monitor

  1994cites this paper
• Activated partial thromboplastin time response to varying, in vitro heparin concentrations: A comparison between a laboratory and a portable method

  1994cites this paper
• Hemostatic abnormalities, anticoagulation and anesthesia

  1994cites this paper
• Quantification of medical and operational factors determining central versus satellite laboratory testing of blood gases.

  1994cites this paper
• Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: a coronary care unit experience.

  1994cites this paper
• Thrombolysis in acute myocardial infarction

  1994cites this paper
• The effect of oral anticoagulant therapy on aptt results from a bedside coagulation monitor

  1994cites this paper
• Coagulation screening tests.

  1994cites this paper
• The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery

  1994cites this paper
• Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation.

  1994cites this paper
• Performance of Gem Premier blood gas/electrolyte analyzer evaluated.

  1993cites this paper
• Oral anticoagulant therapy--50 years later.

  1993cites this paper
• New whole blood analyzers and their impact on cardiac and critical care.

  1993cites this paper
• Comparison of bedside coagulation monitoring tests with standard laboratory tests in patients after cardiac surgery.

  1993cites this paper
• Home monitoring of anticoagulant therapy.

  1993cites this paper
• Quality blood specimens (for potassium measurement) with a standardized finger-incision device.

  1993cites this paper
• Establishing a Therapeutic Range for Heparin Therapy

  1993cites this paper
• Conjunctive heparin therapy. Limitations of subcutaneous administration.

  1992cites this paper
• Simultaneous patient-side measurement of hemoglobin, glucose, and cholesterol in finger-stick blood.

  1992cites this paper
• Monitoring hemostasis in the perioperative period: anticoagulation control.

  1991cites this paper